Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Treatment Access, Health Economics, and the Wave of a Magic Wand.

  • Authors : Stewart DJ; Department of Medicine, Faculty of Medicine, The Ottawa Hospital, University of Ottawa, 501 Smyth Rd., Ottawa, ON K1H 8L6, Canada.; Life Saving Therapies Network, 173 Heath St., Ottawa, ON K1H 5E6, Canada.

Subjects: Drug Costs*; Canada ; Costs and Cost Analysis

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Feb 16; Vol. 29 (2), pp. 1176-1189. Date of Electronic Publication: 2022 Feb 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Access Denied? The Unintended Consequences of Pending Drug Pricing Rules.

Subjects: Drug Costs*; Canada ; Costs and Cost Analysis

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Apr 02; Vol. 29 (4), pp. 2504-2508. Date of Electronic Publication: 2022 Apr 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies.

  • Authors : Ha SY; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.; Kang DW

Subjects: Drug Costs* ; Nivolumab*; Budgets

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Mar 30; Vol. 19 (7). Date of Electronic Publication: 2022 Mar 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Closing the Gaps to Timely Patient Access: Perspectives on Conditional Funding Models.

Subjects: Drug Costs* ; Technology Assessment, Biomedical*; Canada

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Feb 10; Vol. 29 (2), pp. 981-988. Date of Electronic Publication: 2022 Feb 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

How Well Does a Sequential Minimal Optimization Model Perform in Predicting Medicine Prices for Procurement System?

  • Authors : Pentrakan A; Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan.; Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla 90112, Thailand.

Subjects: Drug Costs* ; Drugs, Generic*; Health Expenditures

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 May 21; Vol. 18 (11). Date of Electronic Publication: 2021 May 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario.

  • Authors : Naipaul RD; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Mercer RE

Subjects: Drug Costs*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*economics ; COVID-19/COVID-19/COVID-19/*epidemiology

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Feb 26; Vol. 28 (2), pp. 1056-1066. Date of Electronic Publication: 2021 Feb 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs.

  • Authors : Saluja R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.; Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

Subjects: Drug Costs* ; Pharmaceutical Preparations*; Canada

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Jan 20; Vol. 28 (1), pp. 606-618. Date of Electronic Publication: 2021 Jan 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility.

  • Authors : Jung JH; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.; Novartis Korea Ltd., Seoul 07326, Korea.

Subjects: Antineoplastic Agents* ; Drug Costs*; France

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jan 14; Vol. 18 (2). Date of Electronic Publication: 2021 Jan 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany.

  • Authors : Blankart KE; CINCH-Health Economics Research Center, Faculty of Economics and Business Administration, University of Duisburg-Essen, 45127 Essen, Germany.; Leibniz Science Campus Ruhr, 45030 Essen, Germany.

Subjects: Biosimilar Pharmaceuticals* ; Cost Control* ; Drug Costs*

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Jun 09; Vol. 17 (11). Date of Electronic Publication: 2020 Jun 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.

  • Authors : Stewart DJ; Division of Medical Oncology, University of Ottawa, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.; Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/economics ; Cost-Benefit Analysis*/Cost-Benefit Analysis*/Cost-Benefit Analysis*/methods

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Apr 28; Vol. 31 (5), pp. 2453-2480. Date of Electronic Publication: 2024 Apr 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
  • 1-10 ل  105 نتائج ل ""drug costs""